These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 32525643

  • 1.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Akesson LS, Savarirayan R.
    ; 1993. PubMed ID: 32525643
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility.
    Lindborg CM, Al Mukaddam M, Baujat G, Cho TJ, De Cunto CL, Delai PLR, Eekhoff EMW, Haga N, Hsiao EC, Morhart R, de Ruiter R, Scott C, Seemann P, Szczepanek M, Tabarkiewicz J, Pignolo RJ, Kaplan FS.
    Clin Orthop Relat Res; 2023 Dec 01; 481(12):2447-2458. PubMed ID: 37156007
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Early diagnosis of fibrodysplasia ossificans progressiva.
    Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J, Sillence D, Zackai E, Ravitsky V, Zasloff M, Ganguly A, Shore EM.
    Pediatrics; 2008 May 01; 121(5):e1295-300. PubMed ID: 18450872
    [Abstract] [Full Text] [Related]

  • 7. Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives.
    Smilde BJ, Botman E, de Ruiter RD, Smit JM, Teunissen BP, Lubbers WD, Schwarte LA, Schober P, Eekhoff EMW.
    Orthop Res Rev; 2022 May 01; 14():113-120. PubMed ID: 35480068
    [Abstract] [Full Text] [Related]

  • 8. Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report.
    Singh S, Kidane J, Wentworth KL, Motamedi D, Morshed S, Schober AE, Hsiao EC.
    BMC Musculoskelet Disord; 2020 Apr 03; 21(1):204. PubMed ID: 32245464
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1R206H Mouse Model of Fibrodysplasia Ossificans Progressiva.
    Convente MR, Chakkalakal SA, Yang E, Caron RJ, Zhang D, Kambayashi T, Kaplan FS, Shore EM.
    J Bone Miner Res; 2018 Feb 03; 33(2):269-282. PubMed ID: 28986986
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.
    Yamamoto M, Stoessel SJ, Yamamoto S, Goldhamer DJ.
    J Bone Miner Res; 2022 Nov 03; 37(11):2077-2093. PubMed ID: 35637634
    [Abstract] [Full Text] [Related]

  • 15. Fibrodysplasia Ossificans Progressiva: A Case Series with Radiologic Findings.
    Malik I, Sharma SC, Padhiyar MA, Rawal N, Mukherjee M.
    J Orthop Case Rep; 2022 Nov 03; 12(11):9-13. PubMed ID: 37013240
    [Abstract] [Full Text] [Related]

  • 16. Fibrodysplasia ossificans progressiva in a 3-year-old female patient.
    Moreira C, Dapueto G, Peluffo G, Vomero A, Tapié A, Rodríguez S, Raggio V, Suárez R, Giachetto G, García L.
    Bol Med Hosp Infant Mex; 2023 Nov 03; 80(1):69-73. PubMed ID: 36867574
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.